Seed Grant Program
The AES Seed Grant Program provides support to established investigators to pursue new and innovative directions in epilepsy research, bring new research methods to their research programs, or begin new collaborations with other investigators in epilepsy or in different, complementary disciplines. These small awards are designed to enable preliminary investigations that will lay the groundwork for subsequent substantial grants from government, industry, or other funding sources for research to advance the understanding, treatment, and prevention of epilepsy.
Applications are rapidly reviewed by the AES Research and Training Council according to eligibility, scientific merit and impact, and potential for growth into a larger and ongoing research effort. Seed Grants may provide up to $20,000 for one year for direct costs only, and they may not be renewed. Examples of allowable costs include research project supplies and expenses related to information and technology exchange, such as travel for postdoctoral fellows between collaborating laboratories. The number of awards made each year is contingent on available funds.
March 31, 2017
September 22, 2017
Funding decisions will be announced within six weeks of each application deadline.
- Applications may come from individual investigators or from two or more collaborating investigators. Applicants must be established investigators with at least an Associate Professor or equivalent level appointment. At least one applicant must be an epilepsy-focused academic investigator and an AES member.
- The proposed research must be in a new direction that could not be initiated without Seed support. Proposals are welcome across the spectrum of epilepsy research, including basic, translational, clinical, and outcomes-related research.
- If a project involves a collaboration between two or more investigators, preference will be given to collaborations that are new and/or involve investigators at different institutions or in different disciplines or fields of research. Preference will also be given to collaborations between academic investigators, although collaborations between academic and industry investigators will be considered.
- Applications that propose only infrastructure development with no primary research or data collection will not be accepted.
- Preference will be given to applications for research to be conducted at U.S. institutions. Depending on available funds, applications may be considered from investigators outside the U.S. who otherwise meet the eligibility criteria.
The following application materials must be submitted in PDF format to email@example.com by close of business on the date of the deadline.
- Completed cover sheet [PDF]
- Proposal narrative, including the following (3 pages maximum):
- description of the proposed research and its significance
- overview of the research and technical expertise of the participating laboratories/clinical research sites
- statement describing how the proposed research represents a new direction and why Seed support is essential for its initiation
- future plans for the research beyond the one-year term of the Seed grant
- budget for the requested funding (in U.S. dollars)
- NIH format biosketch for all principal investigators, including present and past funding from the last 3 years
- When human subjects or tissues and/or vertebrate animals are to be used in a research project, it is the responsibility of the grantee to ensure that the project receives approval from his/her Institutional Review Board (IRB) and/or Institutional Animal Care and Use Committee (IACUC). If not submitted with an application selected for an award, documention of necessary approval(s) must be submitted before funding can begin.
* All application materials must be submitted in English. All grants will be funded in U.S. dollars.
Awarded applicants must submit final financial and scientific progress reports within 30 days of the end of the award term, and grantees may also be contacted by AES in subsequent years for periodic assessments of funding outcomes.